Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M9,337Revenue $M7,146Net Margin (%)7.0Z-Score2.9
Enterprise Value $M13,059EPS $5.5Operating Margin %13.6F-Score6
P/E(ttm))18.7Cash Flow Per Share $5.2Pre-tax Margin (%)11.8Higher ROA y-yN
Price/Book2.210-y EBITDA Growth Rate %8.5Quick Ratio1.2Cash flow > EarningsY
Price/Sales1.35-y EBITDA Growth Rate %6.8Current Ratio1.3Lower Leverage y-yN
Price/Cash Flow11.3y-y EBITDA Growth Rate %-20.4ROA % (ttm)5.4Higher Current Ratio y-yY
Dividend Yield %2.0Insider Buy (3m)0ROE % (ttm)12.7Less Shares Outstanding y-yY
Payout Ratio %37.0Shares Outstanding M145ROI % (ttm)5.5Gross Margin Increase y-yN

Gurus Latest Trades with DGX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DGXJoel Greenblatt 2014-09-30 Add0.14%$59.28 - $64.08
($61.73)
$ 64.414%Add 5330.13%238,057
DGXScott Black 2014-09-30 Sold Out $59.28 - $64.08
($61.73)
$ 64.414%Sold Out0
DGXHOTCHKIS & WILEY 2014-09-30 Reduce-0.19%$59.28 - $64.08
($61.73)
$ 64.414%Reduce -36.86%1,593,262
DGXChris Davis 2014-06-30 Add0.8%$55.5 - $61.75
($58.56)
$ 64.4110%Add 4465.97%4,672,681
DGXScott Black 2014-06-30 Buy $55.5 - $61.75
($58.56)
$ 64.4110%New holding, 220 sh.220
DGXRichard Pzena 2014-06-30 Reduce-0.18%$55.5 - $61.75
($58.56)
$ 64.4110%Reduce -55.66%431,100
DGXRobert Olstein 2014-06-30 Reduce-0.14%$55.5 - $61.75
($58.56)
$ 64.4110%Reduce -18%82,000
DGXDavid Dreman 2014-06-30 Reduce-0.06%$55.5 - $61.75
($58.56)
$ 64.4110%Reduce -26.19%35,982
DGXJoel Greenblatt 2014-06-30 Reduce-0.06%$55.5 - $61.75
($58.56)
$ 64.4110%Reduce -94.26%4,384
DGXRay Dalio 2014-06-30 Reduce-0.03%$55.5 - $61.75
($58.56)
$ 64.4110%Reduce -82.85%13,545
DGXHOTCHKIS & WILEY 2014-03-31 Add0.1%$50.8 - $57.99
($53.53)
$ 64.4120%Add 23.69%2,495,500
DGXDavid Dreman 2014-03-31 Add0.09%$50.8 - $57.99
($53.53)
$ 64.4120%Add 66.84%48,748
DGXRay Dalio 2014-03-31 Buy 0.04%$50.8 - $57.99
($53.53)
$ 64.4120%New holding, 78977 sh.78,977
DGXChris Davis 2014-03-31 Buy 0.02%$50.8 - $57.99
($53.53)
$ 64.4120%New holding, 102337 sh.102,337
DGXJoel Greenblatt 2014-03-31 Reduce-0.26%$50.8 - $57.99
($53.53)
$ 64.4120%Reduce -72.63%76,412
DGXJoel Greenblatt 2013-12-31 Add0.3%$52.79 - $63.7
($59.36)
$ 64.418%Add 533.63%279,188
DGXRichard Pzena 2013-12-31 Add0.17%$52.79 - $63.7
($59.36)
$ 64.418%Add 81.17%1,215,050
DGXJohn Rogers 2013-12-31 Add0.15%$52.79 - $63.7
($59.36)
$ 64.418%Add 447.73%268,053
DGXBrian Rogers 2013-12-31 Add0.11%$52.79 - $63.7
($59.36)
$ 64.418%Add 25%2,750,000
DGXDavid Dreman 2013-12-31 Reduce-0.06%$52.79 - $63.7
($59.36)
$ 64.418%Reduce -28.19%29,218
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DGX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
DGX Joel Greenblatt 2014-09-30238,0570.160.14+5330.13%
DGX Ray Dalio 2014-09-3015,6260.010.01+15.36%
DGX Chris Davis 2014-09-304,879,4163.380.92+4.42%
DGX Brian Rogers 2014-09-303,000,0002.080.68
DGX Robert Olstein 2014-09-3082,0000.060.65
DGX Richard Pzena 2014-09-30429,7000.30.14-0.32%
DGX John Rogers 2014-09-30348,9100.240.27-1.14%
DGX David Dreman 2014-09-3033,8980.020.17-5.79%
DGX HOTCHKIS & WILEY 2014-09-301,593,2621.10.35-36.86%
DGX Scott Black 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


DGX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BONGIORNO THOMAS FVP and Corporate Controller 2014-11-18Sell10,000$640.94view
Cohen Jon RSVP and Chief Medical Officer 2014-11-17Sell160,029$63.132.33view
PFEIFFER GARY MDirector 2014-11-10Sell10,000$61.694.72view
Doherty Catherine T.SVP, Physician Services Bus. 2014-11-03Sell23,667$62.193.88view
Doherty Catherine T.SVP, Clinical Franchises 2014-08-08Sell25,000$60.127.45view
PREVOZNIK MICHAEL ESVP & General Counsel 2014-08-04Sell14,377$61.015.88view
PREVOZNIK MICHAEL ESVP & General Counsel 2014-07-30Sell16,384$62.513.34view
BRITELL JENNE KDirector 2014-07-30Sell8,000$62.373.58view
BALDWIN JOHN C MDDirector 2014-07-29Sell8,000$62.313.68view
BONGIORNO THOMAS FVP and Corporate Controller 2014-07-28Sell4,000$61.724.67view

Press Releases about DGX :

    Quarterly/Annual Reports about DGX:

    News about DGX:

    Articles On GuruFocus.com
    DGX: A Healthy Diagnosis Oct 08 2014 
    The Top Five Guru-Held Mid-Cap Stocks of Q2 Sep 04 2014 
    LabCorp: A Leading Independent Diagnostic Laboratory Aug 22 2014 
    Bernard Horn Comments on Quest Diagnostics Aug 07 2014 
    Top Five Guru-Owned Mid Cap Stocks Jun 18 2014 
    Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S May 28 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historic Low P/S May 13 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 05 2014 
    Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S Apr 29 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Apr 28 2014 

    More From Other Websites
    OPTIMIZERx Corp. to Automate Patient Savings and Improve Medication Adherence for Patients Served by... Nov 17 2014
    OPTIMIZERx Corp. to Automate Patient Savings and Improve Medication Adherence for Patients Served by... Nov 17 2014
    Quest Diagnostics upgraded by Deutsche Bank Nov 13 2014
    QUEST DIAGNOSTICS INC Financials Nov 06 2014
    QUEST DIAGNOSTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Nov 05 2014
    Quest Diagnostics (DGX): Stock With Unusual Social Activity Nov 05 2014
    Quest Diagnostics Discusses Progress in Executing Strategy to Drive Shareholder Value and Presents... Nov 05 2014
    Quest Diagnostics Discusses Progress in Executing Strategy to Drive Shareholder Value and Presents... Nov 05 2014
    Quest Diagnostics Introduces BRCAvantage Plus™, Providing New Choices in Genetic Breast Cancer... Nov 04 2014
    LabCorp Diversifies With $6.1 billion Covance Buyout Nov 03 2014
    10-Q for Quest Diagnostics, Inc. Nov 01 2014
    QUEST DIAGNOSTICS INC Files SEC form 10-Q, Quarterly Report Oct 30 2014
    LabCorp Outshines Earnings, Revenues in Q3; Guides Up Oct 28 2014
    Quest Diagnostics Beats on Earnings & Revs, Ups View Oct 23 2014
    Quest Diagnostics Inc Earnings Call scheduled for 8:30 am ET today Oct 23 2014
    [$$] Quest Diagnostics Sees Revenue Increase Oct 23 2014
    Quest Diagnostics beats Street 3Q forecasts Oct 23 2014
    Quest Diagnostics beats Street 3Q forecasts Oct 23 2014
    Q3 2014 Quest Diagnostics Inc Earnings Release - Before Market Open Oct 23 2014
    QUEST DIAGNOSTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Oct 23 2014
    Quest Diagnostics Reports Third Quarter 2014 Financial Results Oct 23 2014
    QUEST DIAGNOSTICS INC Files SEC form 8-K, Change in Directors or Principal Officers Oct 22 2014
    Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors Oct 22 2014
    Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors Oct 22 2014
    Will Quest Diagnostics (DGX) Surprise Earnings in Q3? Oct 21 2014
    Quest Diagnostics To Release Third Quarter 2014 Financial Results On October 23 Oct 07 2014
    Russia sanctions worry hits Wall Street; techs weigh Mar 26 2014
    Focus Diagnostics Receives FDA Clearance for Moderate Complexity Simplexa® HSV 1 & 2 Direct... Mar 24 2014
    Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering Mar 12 2014
    Quest Diagnostics to Acquire Summit Health Mar 12 2014
    Quest Diagnostics Completes Acquisition of Solstas Lab Partners and Raises 2014 Financial Guidance Mar 10 2014
    Quest Diagnostics to Present Interoperability Solutions for Health Systems at HIMSS 2014 Feb 27 2014
    Quest Diagnostics Expands Hereditary Cancer Screening Offering with Lynch Syndrome Blood and Biopsy... Feb 27 2014
    Quest Diagnostics To Speak At The 2014 RBC Capital Markets Global Healthcare Conference Feb 14 2014
    ChartMaxx® from Quest Diagnostics Achieves Meaningful Use 2014 Certification from ICSA Labs Feb 14 2014
    ChartMaxx® from Quest Diagnostics Earns 2013 'Best in KLAS' for Healthcare Document Management and... Feb 05 2014
    Quest Diagnostics to Acquire Solstas Lab Partners Jan 22 2014
    Quest will buy Solstas Lab Partners for $570M Jan 22 2014
    Quest Diagnostics To Release Fourth Quarter And Full Year 2013 Financial Results On January 30 Jan 18 2014
    Quest Diagnostics Adds Timothy L. Main to Board of Directors Jan 14 2014
    UC San Francisco and Quest Diagnostics Launch Collaboration to Advance the Field of Precision... Jan 09 2014
    Illumina to Provide Next-Generation Sequencing (NGS) Technologies to Quest Diagnostics Jan 09 2014
    Life Technologies to Provide Ion Torrent Sequencing Platform to Quest Diagnostics for Development of... Jan 09 2014
    Quest Diagnostics Updates Revenue and Adjusted Diluted EPS Guidance for Full-Year 2013 Dec 13 2013
    US STOCKS-Fed taper anxiety triggers profit taking on Wall St Dec 11 2013
    BRCAvantage™ from Quest Diagnostics to Make Medical Congress Debut at the 2013 San Antonio Breast... Dec 11 2013

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK